OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

CUSIP: 67576A100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
214,467,875
Total 13F shares
39,631,821
Share change
-3,178,543
Total reported value
$111,363,550
Put/Call ratio
82%
Price per share
$2.81
Number of holders
110
Value change
-$11,852,132
Number of buys
49
Number of sells
65

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q4 2022

As of 31 Dec 2022, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,631,821 shares. The largest 10 holders included SUMMER ROAD LLC, Opaleye Management Inc., BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, DELTEC ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Endurant Capital Management LP, and D. E. Shaw & Co., Inc.. This page lists 110 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.